Institutions · Entity Annotation Prototype (beta)

14articles mentioning institutions

17institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: MD Anderson Cancer Center ×

MD Anderson Cancer Center

This institution is selected. Its supporting articles are shown below.

MD Anderson Cancer Center14

Articles mentioning MD Anderson Cancer Center

14 articles · page 2 of 2

658 KAN-001, a defined live biotherapeutic product (LBP) for NSCLC, enhances ICI response in preclinical models and demonstrates manufacturing consistency and strain-resolved viability

jitc · abstract · 2025-11-04 · 1 matching annotations

96.5%

MD Anderson Cancer Center CRCHUM KAN-001 non-small cell lung cancer NSCLC anti-PD-1 therapy Canadian Council PD-1 therapy

…Acknowledgements We thank Nadim Ajami and Jennifer Wargo of the MD Anderson Cancer Center for their continued support of the KAN-001 program.Ethics Appro…

838 Preservation of vaccine-induced CD8+ memory T cells by melanoma-cognate CD4+ T cells in a human clinical trial

jitc · abstract · 2025-11-04 · 1 matching annotations

89.2%

University of Virginia Fox Chase Cancer Center MD Anderson Cancer Center University of Texas – Houston 6MHP melanoma ClinicalTrials.gov cyclophosphamide recurrent tumors 12MP

…sity of Texas – Houston, and Fox Chase Cancer Center), with the University of Virginia at the lead institution; approval number: IRB-HSR #11491.Abstra…